{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:00:49Z","timestamp":1786122049967,"version":"build-2736575974"},"reference-count":87,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172882"],"award-info":[{"award-number":["82172882"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017366","name":"Key Research and Development Program of Heilongjiang","doi-asserted-by":"publisher","award":["2023ZX06C09"],"award-info":[{"award-number":["2023ZX06C09"]}],"id":[{"id":"10.13039\/100017366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fundamental Research"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.fmre.2026.03.016","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T17:12:25Z","timestamp":1775495545000},"page":"2355-2365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chromatin regulator expression patterns predict prognosis and guide neoadjuvant therapy in esophageal squamous cell carcinoma"],"prefix":"10.1016","volume":"6","author":[{"given":"Jia","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangcong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengxiang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8403-928X","authenticated-orcid":false,"given":"Chenghao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.fmre.2026.03.016_bib0001","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"9864","key":"10.1016\/j.fmre.2026.03.016_bib0002","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0140-6736(12)60643-6","article-title":"Oesophageal carcinoma","volume":"381","author":"Pennathur","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.fmre.2026.03.016_bib0003","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.fmre.2026.03.016_bib0004","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15290","article-title":"Genomic analysis of oesophageal squamous-cell carcinoma identifies alcohol drinking-related mutation signature and genomic alterations","volume":"8","author":"Chang","year":"2017","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.fmre.2026.03.016_bib0005","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ajhg.2015.12.013","article-title":"Whole-genome sequencing reveals diverse models of structural variations in esophageal squamous cell carcinoma","volume":"98","author":"Cheng","year":"2016","journal-title":"Am. J. Hum. Genet."},{"issue":"10","key":"10.1016\/j.fmre.2026.03.016_bib0006","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/s41422-020-0333-6","article-title":"Whole-genome sequencing of 508 patients identifies key molecular features associated with poor prognosis in esophageal squamous cell carcinoma","volume":"30","author":"Cui","year":"2020","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.fmre.2026.03.016_bib0007","doi-asserted-by":"crossref","first-page":"5870","DOI":"10.1038\/s41467-020-19641-9","article-title":"Author correction: Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinoma","volume":"11","author":"Yan","year":"2020","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.fmre.2026.03.016_bib0008","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/ng.3650","article-title":"Noncoding somatic and inherited single-nucleotide variants converge to promote ESR1 expression in breast cancer","volume":"48","author":"Bailey","year":"2016","journal-title":"Nat. Genet."},{"issue":"46","key":"10.1016\/j.fmre.2026.03.016_bib0009","doi-asserted-by":"crossref","first-page":"eaba6784","DOI":"10.1126\/sciadv.aba6784","article-title":"DORGE: Discovery of oncogenes and tumoR suppressor genes using genetic and epigenetic features","volume":"6","author":"Lyu","year":"2020","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.fmre.2026.03.016_bib0010","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41556-018-0258-1","article-title":"Chromatin regulatory mechanisms and therapeutic opportunities in cancer","volume":"21","author":"Valencia","year":"2019","journal-title":"Nat. Cell Biol."},{"issue":"6","key":"10.1016\/j.fmre.2026.03.016_bib0011","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.molonc.2012.09.005","article-title":"Chromatin remodeling in cancer: A gateway to regulate gene transcription","volume":"6","author":"Nair","year":"2012","journal-title":"Mol. Oncol."},{"issue":"1","key":"10.1016\/j.fmre.2026.03.016_bib0012","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41420-024-01803-z","article-title":"Cancer epigenetics: From laboratory studies and clinical trials to precision medicine","volume":"10","author":"Yu","year":"2024","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.fmre.2026.03.016_bib0013","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12943-024-02100-0","article-title":"Unraveling the key role of chromatin structure in cancer development through epigenetic landscape characterization of oral cancer","volume":"23","author":"Xue","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.fmre.2026.03.016_bib0014","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41540-018-0061-4","article-title":"A network of epigenomic and transcriptional cooperation encompassing an epigenomic master regulator in cancer","volume":"4","author":"Wilson","year":"2018","journal-title":"NPJ Syst. Biol. Appl."},{"issue":"D1","key":"10.1016\/j.fmre.2026.03.016_bib0015","doi-asserted-by":"crossref","first-page":"D918","DOI":"10.1093\/nar\/gkx877","article-title":"CR2Cancer: A database for chromatin regulators in human cancer","volume":"46","author":"Ru","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.fmre.2026.03.016_bib0016","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/cas.14311","article-title":"Synthetic lethal therapy based on targeting the vulnerability of SWI\/SNF chromatin remodeling complex-deficient cancers","volume":"111","author":"Sasaki","year":"2020","journal-title":"Cancer Sci."},{"issue":"5","key":"10.1016\/j.fmre.2026.03.016_bib0017","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.cell.2017.01.021","article-title":"CpG island hypermethylation mediated by DNMT3A is a consequence of AML progression","volume":"168","author":"Spencer","year":"2017","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.fmre.2026.03.016_bib0018","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a030320","article-title":"DNMT3A in leukemia","volume":"7","author":"Brunetti","year":"2017","journal-title":"Cold Spring Harb Perspect Med."},{"issue":"8","key":"10.1016\/j.fmre.2026.03.016_bib0019","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3390\/cancers13081769","article-title":"Treatment strategies for ARID1A-deficient ovarian clear cell carcinoma","volume":"13","author":"Takahashi","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.fmre.2026.03.016_bib0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2019.0347","article-title":"Epigenetic N6-methyladenosine modification of RNA and DNA regulates cancer","volume":"17","author":"Liang","year":"2020","journal-title":"Cancer Biol. Med."},{"issue":"1","key":"10.1016\/j.fmre.2026.03.016_bib0021","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.molcel.2017.12.006","article-title":"N(6)-methyladenosines modulate A-to-I RNA editing","volume":"69","author":"Xiang","year":"2018","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.fmre.2026.03.016_bib0022","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41589-021-00920-5","article-title":"Small molecule targeting of chromatin writers in cancer","volume":"18","author":"Conery","year":"2022","journal-title":"Nat. Chem. Biol."},{"issue":"7","key":"10.1016\/j.fmre.2026.03.016_bib0023","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1158\/0008-5472.CAN-15-2125","article-title":"Combining epigenetic and immunotherapy to combat cancer","volume":"76","author":"Chiappinelli","year":"2016","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.fmre.2026.03.016_bib0024","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.it.2020.06.002","article-title":"The contribution of epigenetics to cancer immunotherapy","volume":"41","author":"Villanueva","year":"2020","journal-title":"Trends Immunol."},{"issue":"7866","key":"10.1016\/j.fmre.2026.03.016_bib0025","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41586-021-03520-4","article-title":"Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity","volume":"595","author":"Griffin","year":"2021","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.fmre.2026.03.016_bib0026","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/ncb1974","article-title":"KLF17 is a negative regulator of epithelial-mesenchymal transition and metastasis in breast cancer","volume":"11","author":"Gumireddy","year":"2009","journal-title":"Nat. Cell Biol."},{"issue":"4","key":"10.1016\/j.fmre.2026.03.016_bib0027","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ccell.2020.03.005","article-title":"KMT2D Deficiency impairs super-enhancers to confer a glycolytic vulnerability in lung cancer","volume":"37","author":"Alam","year":"2020","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.fmre.2026.03.016_bib0028","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/s41590-020-0700-y","article-title":"Tet2 and Tet3 in B cells are required to repress CD86 and prevent autoimmunity","volume":"21","author":"Tanaka","year":"2020","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.fmre.2026.03.016_bib0029","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1038\/s41467-020-17227-z","article-title":"Multi-faceted epigenetic dysregulation of gene expression promotes esophageal squamous cell carcinoma","volume":"11","author":"Cao","year":"2020","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.fmre.2026.03.016_bib0030","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2353\/ajpath.2009.081142","article-title":"Epigenetic dysregulation in cancer","volume":"175","author":"Muntean","year":"2009","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.fmre.2026.03.016_bib0031","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12943-021-01464-x","article-title":"Epigenetic modulation of antitumor immunity for improved cancer immunotherapy","volume":"20","author":"Dai","year":"2021","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.fmre.2026.03.016_bib0032","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13045-018-0663-8","article-title":"Long non-coding RNAs in esophageal cancer: Molecular mechanisms, functions, and potential applications","volume":"11","author":"Su","year":"2018","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.fmre.2026.03.016_bib0033","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41572-020-0160-6","article-title":"Immune-related adverse events of checkpoint inhibitors","volume":"6","author":"Ramos-Casals","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"5","key":"10.1016\/j.fmre.2026.03.016_bib0034","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.annonc.2021.02.004","article-title":"Checkpoint inhibitors for gastroesophageal cancers: Dissecting heterogeneity to better understand their role in first-line and adjuvant therapy","volume":"32","author":"Smyth","year":"2021","journal-title":"Ann. Oncol."},{"issue":"10","key":"10.1016\/j.fmre.2026.03.016_bib0035","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nbt.1678","article-title":"Epigenetic modifications as therapeutic targets","volume":"28","author":"Kelly","year":"2010","journal-title":"Nat. Biotechnol."},{"issue":"4","key":"10.1016\/j.fmre.2026.03.016_bib0036","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/annonc\/mdy050","article-title":"Epigenetic modifiers as new immunomodulatory therapies in solid tumours","volume":"29","author":"Aspeslagh","year":"2018","journal-title":"Ann. Oncol."},{"issue":"11","key":"10.1016\/j.fmre.2026.03.016_bib0037","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1136\/gutjnl-2013-305806","article-title":"LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma","volume":"63","author":"Li","year":"2014","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.fmre.2026.03.016_bib0038","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004291","article-title":"Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma","volume":"10","author":"Liu","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.fmre.2026.03.016_bib0039","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1023\/A:1023818214614","article-title":"Isometric logratio transformations for compositional data analysis","volume":"35","author":"Egozcue","year":"2003","journal-title":"Math. Geol."},{"issue":"17","key":"10.1016\/j.fmre.2026.03.016_bib0040","doi-asserted-by":"crossref","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","article-title":"fastp: An ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"},{"issue":"4","key":"10.1016\/j.fmre.2026.03.016_bib0041","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.3317","article-title":"HISAT: A fast spliced aligner with low memory requirements","volume":"12","author":"Kim","year":"2015","journal-title":"Nat. Methods"},{"issue":"3","key":"10.1016\/j.fmre.2026.03.016_bib0042","doi-asserted-by":"crossref","first-page":"R22","DOI":"10.1186\/gb-2011-12-3-r22","article-title":"Improving RNA-seq expression estimates by correcting for fragment bias","volume":"12","author":"Roberts","year":"2011","journal-title":"Genome Biol."},{"issue":"9","key":"10.1016\/j.fmre.2026.03.016_bib0043","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrg.2017.33","article-title":"TET-mediated active DNA demethylation: Mechanism, function and beyond","volume":"18","author":"Wu","year":"2017","journal-title":"Nat. Rev. Genet."},{"issue":"Pt 3","key":"10.1016\/j.fmre.2026.03.016_bib0044","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1042\/bj20021321","article-title":"Histone deacetylases (HDACs): Characterization of the classical HDAC family","volume":"370","author":"de Ruijter","year":"2003","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.fmre.2026.03.016_bib0045","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrg.2017.80","article-title":"The DNA methyltransferase family: A versatile toolkit for epigenetic regulation","volume":"19","author":"Lyko","year":"2018","journal-title":"Nat. Rev. Genet."},{"issue":"1","key":"10.1016\/j.fmre.2026.03.016_bib0046","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1145\/151480.151483","article-title":"HDM\u2014a model-based approach to hypertext application design","volume":"11","author":"Garzotto","year":"1993","journal-title":"ACM Trans. Information Syst."},{"issue":"2","key":"10.1016\/j.fmre.2026.03.016_bib0047","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1128\/MMBR.64.2.435-459.2000","article-title":"Acetylation of histones and transcription-related factors","volume":"64","author":"Sterner","year":"2000","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"3","key":"10.1016\/j.fmre.2026.03.016_bib0048","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1615\/CritRevEukaryotGeneExpr.v14.i3.10","article-title":"Structure and function of histone methyltransferases","volume":"14","author":"Trievel","year":"2004","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"10.1016\/j.fmre.2026.03.016_bib0049","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3389\/fonc.2019.00489","article-title":"DNA methylation readers and cancer: Mechanistic and therapeutic applications","volume":"9","author":"Mahmood","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.fmre.2026.03.016_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108614","article-title":"Chemical inhibitors targeting histone methylation readers","volume":"256","author":"Huang","year":"2024","journal-title":"Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.fmre.2026.03.016_bib0051","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nrc3068","article-title":"SWI\/SNF nucleosome remodellers and cancer","volume":"11","author":"Wilson","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.fmre.2026.03.016_bib0052","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.gene.2013.05.088","article-title":"SIR-nucleosome interactions: Structure-function relationships in yeast silent chromatin","volume":"527","author":"Oppikofer","year":"2013","journal-title":"Gene"},{"issue":"8","key":"10.1016\/j.fmre.2026.03.016_bib0053","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nrc3091","article-title":"Cancer biology and NuRD: A multifaceted chromatin remodelling complex","volume":"11","author":"Lai","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.fmre.2026.03.016_bib0054","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3892\/mmr.2024.13358","article-title":"Advances in research on the relationship between the LMNA gene and human diseases (Review)","volume":"30","author":"Zhao","year":"2024","journal-title":"Mol. Med. Rep."},{"issue":"11","key":"10.1016\/j.fmre.2026.03.016_bib0055","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.3390\/ijms17111849","article-title":"The bromodomain and extra-terminal domain (BET) Family: Functional anatomy of BET paralogous proteins","volume":"17","author":"Taniguchi","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"7701","key":"10.1016\/j.fmre.2026.03.016_bib0056","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41586-018-0021-6","article-title":"Structure and regulation of the human INO80-nucleosome complex","volume":"556","author":"Ayala","year":"2018","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.fmre.2026.03.016_bib0057","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41594-019-0199-9","article-title":"Structures of the ISWI-nucleosome complex reveal a conserved mechanism of chromatin remodeling","volume":"26","author":"Yan","year":"2019","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"9","key":"10.1016\/j.fmre.2026.03.016_bib0058","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/s41573-024-00978-5","article-title":"Chromatin remodellers as therapeutic targets","volume":"23","author":"Malone","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.fmre.2026.03.016_bib0059","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation (Camb)"},{"issue":"5","key":"10.1016\/j.fmre.2026.03.016_bib0060","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: An R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"10.1016\/j.fmre.2026.03.016_bib0061","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","article-title":"Profiling tumor infiltrating immune cells with CIBERSORT","volume":"1711","author":"Chen","year":"2018","journal-title":"Methods Mol. Biol."},{"issue":"2","key":"10.1016\/j.fmre.2026.03.016_bib0062","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jjcc.2020.08.004","article-title":"Immune cell infiltration landscapes in pediatric acute myocarditis analyzed by CIBERSORT","volume":"77","author":"Kawada","year":"2021","journal-title":"J. Cardiol."},{"issue":"5","key":"10.1016\/j.fmre.2026.03.016_bib0063","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-011363","article-title":"Development and validation of the Immune Profile Score (IPS), a novel multiomic algorithmic assay for stratifying outcomes in a real-world cohort of patients with advanced solid cancer treated with immune checkpoint inhibitors","volume":"13","author":"Zander","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.fmre.2026.03.016_bib0064","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/jcp.29878","article-title":"Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma","volume":"236","author":"Zhao","year":"2021","journal-title":"J. Cell Physiol."},{"issue":"28","key":"10.1016\/j.fmre.2026.03.016_bib0065","doi-asserted-by":"crossref","first-page":"44129","DOI":"10.18632\/oncotarget.9866","article-title":"Silencing DNA methyltransferase 1 (DNMT1) inhibits proliferation, metastasis and invasion in ESCC by suppressing methylation of RASSF1A and DAPK","volume":"7","author":"Bai","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.fmre.2026.03.016_bib0066","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12957-015-0557-y","article-title":"Methylation of RASSF1A gene promoter and the correlation with DNMT1 expression that may contribute to esophageal squamous cell carcinoma","volume":"13","author":"Du","year":"2015","journal-title":"World J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.fmre.2026.03.016_bib0067","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep."},{"issue":"17","key":"10.1016\/j.fmre.2026.03.016_bib0068","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.150203","article-title":"Genomic and epigenomic evolution of acquired resistance to combination therapy in esophageal squamous cell carcinoma","volume":"6","author":"Min","year":"2021","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.fmre.2026.03.016_bib0069","doi-asserted-by":"crossref","first-page":"e1283","DOI":"10.1002\/ctm2.1283","article-title":"HRG inhibits liver cancer lung metastasis by suppressing neutrophil extracellular trap formation","volume":"13","author":"Yin","year":"2023","journal-title":"Clin. Transl. Med."},{"issue":"5","key":"10.1016\/j.fmre.2026.03.016_bib0070","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200276","article-title":"Antibodies against ZSCAN1 in pediatric and adult patients with non-paraneoplastic ROHHAD syndrome","volume":"11","author":"Serafim","year":"2024","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"2","key":"10.1016\/j.fmre.2026.03.016_bib0071","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/ana.26380","article-title":"ZSCAN1 Autoantibodies are associated with pediatric paraneoplastic ROHHAD","volume":"92","author":"Mandel-Brehm","year":"2022","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.fmre.2026.03.016_bib0072","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.3390\/ijms25031794","article-title":"Anti-ZSCAN1 autoantibodies are a feasible diagnostic marker for ROHHAD syndrome not associated with a tumor","volume":"25","author":"Nakamura-Utsunomiya","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"23","key":"10.1016\/j.fmre.2026.03.016_bib0073","doi-asserted-by":"crossref","first-page":"10434","DOI":"10.7150\/thno.47286","article-title":"HRG switches TNFR1-mediated cell survival to apoptosis in hepatocellular carcinoma","volume":"10","author":"Zou","year":"2020","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.fmre.2026.03.016_bib0074","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2025.2501780","article-title":"Silencing ZIC5 suppresses glycolysis and promotes disulfidptosis in lung adenocarcinoma cells","volume":"26","author":"Zeng","year":"2025","journal-title":"Cancer Biol. Ther."},{"issue":"1","key":"10.1016\/j.fmre.2026.03.016_bib0075","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s41420-022-01181-4","article-title":"AR-regulated ZIC5 contributes to the aggressiveness of prostate cancer","volume":"8","author":"Tan","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.fmre.2026.03.016_bib0076","article-title":"Zic family member 5 promotes survival in human pancreatic cancer and cholangiocarcinoma cells","volume":"31","author":"Satow","year":"2022","journal-title":"Biochem. Biophys. Rep."},{"issue":"3","key":"10.1016\/j.fmre.2026.03.016_bib0077","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.21037\/jgo-22-335","article-title":"ZIC5 promotes human hepatocellular carcinoma cell proliferation through upregulating COL1A1","volume":"13","author":"Song","year":"2022","journal-title":"J. Gastrointest. Oncol."},{"issue":"11","key":"10.1016\/j.fmre.2026.03.016_bib0078","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: From T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.fmre.2026.03.016_bib0079","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115891","article-title":"Advances and challenges in the treatment of lung cancer","volume":"169","author":"Li","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.fmre.2026.03.016_bib0080","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","article-title":"The history and advances in cancer immunotherapy: Understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications","volume":"17","author":"Zhang","year":"2020","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.fmre.2026.03.016_bib0081","article-title":"Immune checkpoint inhibitor-related pneumonitis: Research advances in prediction and management","volume":"15","author":"Lin","year":"2024","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.fmre.2026.03.016_bib0082","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.trecan.2023.04.002","article-title":"Immune mechanisms of toxicity from checkpoint inhibitors","volume":"9","author":"Wang","year":"2023","journal-title":"Trends. Cancer"},{"key":"10.1016\/j.fmre.2026.03.016_bib0083","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.804597","article-title":"Holistic approach to immune checkpoint inhibitor-related adverse events","volume":"13","author":"Poto","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.fmre.2026.03.016_bib0084","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12964-022-00854-y","article-title":"Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons","volume":"20","author":"Naimi","year":"2022","journal-title":"Cell Commun. Signal."},{"issue":"16","key":"10.1016\/j.fmre.2026.03.016_bib0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241612622","article-title":"Immune checkpoint inhibitors in \u201cspecial\u201d NSCLC populations: A viable approach?","volume":"24","author":"Bronte","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.fmre.2026.03.016_bib0086","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13045-020-01027-5","article-title":"Regulation of PD-L1 expression in the tumor microenvironment","volume":"14","author":"Yi","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.fmre.2026.03.016_bib0087","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.jtho.2020.01.017","article-title":"Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC","volume":"15","author":"Gao","year":"2020","journal-title":"J. Thorac. Oncol."}],"container-title":["Fundamental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667325826002013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667325826002013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T07:54:52Z","timestamp":1786089292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667325826002013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":87,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2667325826002013"],"URL":"https:\/\/doi.org\/10.1016\/j.fmre.2026.03.016","relation":{},"ISSN":["2667-3258"],"issn-type":[{"value":"2667-3258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chromatin regulator expression patterns predict prognosis and guide neoadjuvant therapy in esophageal squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Fundamental Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fmre.2026.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Publishing Services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}